Anti-inflamation effect of Bromfenac ophthalmic solution after selective laser trabeculoplasty.
Not Applicable
Completed
- Conditions
- Primary Open Angle Glaucoma
- Registration Number
- JPRN-UMIN000001172
- Lead Sponsor
- Kozawa Eye Hospital and Diabetes Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Eyes allergic to bromfenac or steriod ophthalmic solution. Eyes previously underwent intraocular surgery or laser surgery of any type within 3 months. Eyes with history of PE glaucoma, uveitis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Best corrected visual acuity, intraocular pressure, amount of anterior chamber cells and flare measured by laser cell flare photometry, number of corneal endthelial cells. recorded each visit, preoperatively, 1day, 1 week, 1month, 3month, 6month after selective laser trabeculoplasty.
- Secondary Outcome Measures
Name Time Method